Evidence map›Paper›PMID 39007397›Full record

ArticleDevelopment (Cambridge, England)2024

A large-scale CRISPR screen reveals context-specific genetic regulation of retinal ganglion cell regeneration.

Kevin Emmerich, John Hageter, Thanh Hoang, Pin Lyu, Abigail V Sharrock, Anneliese Ceisel, James Thierer, Zeeshaan Chunawala, Saumya Nimmagadda, Isabella Palazzo and 15 more

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Mesenchymal-derived neural progenitors underlie localbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Kevin EmmerichWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
John HageterDepartment of Biology, West Virginia University, Morgantown, WV 26505, USA.
Thanh HoangWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Pin LyuWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Abigail V SharrockSchool of Biological Sciences, Victoria University of Wellington, Wellington 6012, New Zealand.
Anneliese CeiselWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
James ThiererWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Zeeshaan ChunawalaWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Saumya NimmagaddaWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Isabella PalazzoInstitute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Frazer MatthewsWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Liyun ZhangWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
David T WhiteWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Catalina RodriguezWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Gianna GrazianoWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Patrick MarcosWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Adam MayWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Tim MulliganWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Barak ReibmanWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Meera T SaxenaWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
David F AckerleySchool of Biological Sciences, Victoria University of Wellington, Wellington 6012, New Zealand.
Jiang QianWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Seth BlackshawWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-1338-8476
Eric HorstickDepartment of Biology, West Virginia University, Morgantown, WV 26505, USA.
Jeff S MummWilmer Eye Institute and the Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-2575-287X

Funding

Wilmer Core Grant for Vision ResearchP30EY001765 · NEI · JOHNS HOPKINS UNIVERSITY · PI JEFFREY MUMM · 1985 to 2026
$22.1M
VS-CoBRE Administrative CoreP20GM144230 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Shian Liu · 2022 to 2026
$13.9M
Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Visual Science Training ProgramT32EY007143 · NEI · JOHNS HOPKINS UNIVERSITY · PI Laura Ensign, JEREMY NATHANS · 1995 to 2026
$6.2M
Genetic and Chemical Screens for Factors Regulating Retinal RegenerationR01EY022810 · NEI · JOHNS HOPKINS UNIVERSITY · PI MUMM, JEFFREY · 2013 to 2017
$2.1M
Novel models of Alzheimer's Disease and Related Disorders enabling systematic investigation of the therapeutic potential of transplanted hiPSC-derived cells and endogenous adult neural stem cellsR01OD020376 · OD · JOHNS HOPKINS UNIVERSITY · PI MUMM, JEFFREY · 2016 to 2020
$2.1M
Identification of gene regulatory networks that control proliferative and neurogenic competence in mammalian Müller gliaR01EY031685 · NEI · JOHNS HOPKINS UNIVERSITY · PI BLACKSHAW, SETH · 2020 to 2023
$2.0M
Cell and Molecular Biology Training Program at West Virginia UniversityT32GM133369 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Zoica Cerasela Dinu, MICHAEL D SCHALLER · 2019 to 2026
$2.0M
Identification of gene regulatory networks controlling temporal patterning in retinal progenitor cells and neurogenic Müller gliaR01EY036173 · NEI · JOHNS HOPKINS UNIVERSITY · PI Seth Blackshaw · 2024 to 2026
$2.0M
High-throughput Phenotypic Screening (HPS) Platform for Large-scale Drug Discovery in Whole-organism and Human Organoid-based Disease ModelsS10OD026909 · OD · JOHNS HOPKINS UNIVERSITY · PI MUMM, JEFFREY · 2020 to 2020
$1.9M
Innate immune system regulation of retinal regenerationR01EY033009 · NEI · JOHNS HOPKINS UNIVERSITY · PI MUMM, JEFFREY · 2022 to 2024
$1.3M
Identification of Cellular, Molecular and Genetic Factors Regulating RGC RegenerationF31EY032790 · NEI · JOHNS HOPKINS UNIVERSITY · PI EMMERICH, KEVIN · 2021 to 2024
$112k
Brightfocus Foundation G2020315BrightFocus Foundation G2020315Johns Hopkins University School of MedicineNational Science Foundation OIA-2242771NEI NIH HHS F31 EY032790NEI NIH HHS P30 EY001765NEI NIH HHS R01 EY022810NEI NIH HHS R01 EY031685NEI NIH HHS R01 EY033009NEI NIH HHS R01 EY036173NEI NIH HHS T32 EY007143NIGMS NIH HHS P20 GM144230NIGMS NIH HHS T32 GM133369NIGMS NIH HHS T32 GM136577NIH HHS EY032790-01NIH HHS F31EY032790NIH HHS R01 OD020376NIH HHS S10 OD026909U.S. National Science Foundation OIA2242771
6 · The paper itself

Abstract

Many genes are known to regulate retinal regeneration after widespread tissue damage. Conversely, genes controlling regeneration after limited cell loss, as per degenerative diseases, are undefined. As stem/progenitor cell responses scale to injury levels, understanding how the extent and specificity of cell loss impact regenerative processes is important. Here, transgenic zebrafish enabling selective retinal ganglion cell (RGC) ablation were used to identify genes that regulate RGC regeneration. A single cell multiomics-informed screen of 100 genes identified seven knockouts that inhibited and 11 that promoted RGC regeneration. Surprisingly, 35 out of 36 genes known and/or implicated as being required for regeneration after widespread retinal damage were not required for RGC regeneration. The loss of seven even enhanced regeneration kinetics, including the proneural factors neurog1, olig2 and ascl1a. Mechanistic analyses revealed that ascl1a disruption increased the propensity of progenitor cells to produce RGCs, i.e. increased 'fate bias'. These data demonstrate plasticity in the mechanism through which Müller glia convert to a stem-like state and context specificity in how genes function during regeneration. Increased understanding of how the regeneration of disease-relevant cell types is specifically controlled will support the development of disease-tailored regenerative therapeutics.

Indexed as

Animals, Genetically ModifiedRetinal Ganglion CellsZebrafishZebrafish ProteinsAnimalsBasic Helix-Loop-Helix ProteinsCRISPR-Cas SystemsNerve RegenerationRegenerationRetinaStem CellsTranscription FactorsAscl1a protein, zebrafishBasic Helix-Loop-Helix ProteinsTranscription FactorsZebrafish ProteinsAscl1CRISPR screenNeural stem cellRegenerationRetina

Identifiers

PMID39007397
PMCPMC11361637

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.